Takafumi Shima

Osaka University of Pharmaceutical Sciences

Papers

2

Total Citations

7

H-Index

2

About

Dr. Takafumi Shima is a rising surgical oncologist whose work centers on advancing minimally invasive techniques for colorectal cancer, with a particular focus on robotic surgery. His research leverages large-scale, real-world data to evaluate surgical outcomes and healthcare economics, as demonstrated by his landmark 2024 study comparing laparoscopic versus robotic surgery for rectal cancer. Using the Japanese nationwide inpatient database, this work provided critical evidence on short-term outcomes and perioperative costs, garnering early attention with 5 citations and offering valuable insights for surgical decision-making. Dr. Shima also explores the complex intersection of oncology and systemic disease, as seen in his 2025 case report on robot-assisted surgery for rectal cancer in a patient with tumor-associated dermatomyositis during preoperative chemotherapy. This contribution highlights his clinical acumen and ability to manage high-risk, multidisciplinary cases. By combining rigorous database analysis with nuanced clinical reporting, Dr. Shima is helping to define best practices in robotic colorectal surgery, making his work essential reading for surgeons and researchers interested in evidence-based innovation, cost-effectiveness, and the personalized management of cancer patients with comorbid conditions.

Research Focus

Key Achievements

2
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of short‐term outcomes and perioperative costs in laparoscopic versus robotic surgery for rectal cancers: A real‐world cohort study using Japanese nationwide inpatient database
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago